A cost-effectiveness analysis of rivaroxaban in combination with acetylsalicylic acid (ASA) in adult patients with coronary artery disease (CAD) or symptomatic peripheral artery disease (PAD) at high risk of ischaemic events

B. Pinheiro, M. Gouveia, J. Alarcão, R. Ascenção, M. Borges

Research output: Contribution to journalMeeting Abstractpeer-review

Search results